Biotech China 2014

Biology: Harvard University

Total Score People Score Events Score
359 266 112
Date Event Presentation Speakers
May 28, 2014 79th Cold Spring Harbor Symposium on Quantitative Biology 79th Cold Spring Harbor Symposium on Quantitative Biology Elizabeth Spelke, Catherine Dulac, Markus Meister, Hopi E. Hoekstra
May 23, 2014 (E2) Keystone Symposia: Autophagy: Fundamentals to Disease Pharmacological Manipulation of Autophagy Registered attendees can view abstracts starting on 04/23/2014 Junying Yuan
March 9, 2014 (X4) Keystone Symposia: HIV Pathogenesis - Virus vs. Host Novel Mechanisms for Vaccine-Induced Protection Registered attendees can view abstracts starting on 02/09/2014 Silke Paust,
February 4, 2014 Cancer Epigenetics (Q1) Keynote Address (Joint) Registered attendees can view abstracts starting on 01/04/2014 James E. Bradner
Transcription Factors and Cofactors Registered attendees can view abstracts starting on 01/04/2014 Martha L Bulyk
Genomic Profiles of Chromatin Modifiers in Cancer Registered attendees can view abstracts starting on 01/04/2014 Kornelia Polyak
Transcription, Development and Disease Registered attendees can view abstracts starting on 01/04/2014 Leonard I. Zon
Cellular and Global Views of Transcription Registered attendees can view abstracts starting on 01/04/2014 Job Dekker
February 2, 2014 Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7) Cancer Cell of Origin Registered attendees can view abstracts starting on 01/02/2014 Leonard I. Zon
January 19, 2014 (J5) Keystone Symposia: Pathogenesis of Respiratory Viruses Regulation and Resolution of Inflammation Registered attendees can view abstracts starting on 12/19/2013 Bruce D. Levy
January 17, 2014 (J3) Keystone Symposia: Emerging Cytokine Networks T Cells in Inflammatory Diseases Registered attendees can view abstracts starting on 12/17/2013 K. . Frank Austen
Translational Research Registered attendees can view abstracts starting on 12/17/2013 Howard Weiner, David A. Hafler
Environmental Factors that Influence Immunity Registered attendees can view abstracts starting on 12/17/2013 Vijay Kuchroo
January 7, 2014 Keystone Symposia: Sensing and Signaling of Hypoxia: Interfaces with Biology and Medicine (A1) Keynote Address Registered attendees can view abstracts starting on 12/07/2013 William G Kaelin
January 5, 2014 Gordon Research Conference: Protein Folding Dynamics Discussion Leader: Lila Gierasch (University of Massachusetts Amherst) "Introduction" Lila Gierasch
Linking Protein Folding to Biology, One Mutation at a Time Eugene Shaknovitch
November 21, 2013 Cell Symposia: Using Stem Cells to Model and Treat Human Disease Modeling Genetic Blood Disease with iPS Cells George Daley
Using stem cells to dissect the population architecture of complex neurological disease: a case study in ALS Kevin Eggan
Genome editing to generate human cellular disease models Chad Cowan
Using stem cells to discover pathways that regulate repair and malignancy in skeletal muscle Session V – Stem cells in clinical trials Amy J. Wagers
Finding suppressors of disease-associated phenotypes using a cross-species comparison of tissue production from stem cells Leonard I. Zon
Panel on Overcoming Barriers for Translation of Stem Cell research Leonard I. Zon
October 31, 2013 (T1) Keystone Symposia: Advancing Vaccines in the Genomics Era Systems Biological Approaches to Vaccination Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Ofer Levy
Poster Viewing Ofer Levy
Immunology of Vaccination in the Young and Elderly Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Ofer Levy
October 17, 2013 14th Annual G Protein-Coupled Receptor (GPCR) Retreat Noncanonical GPCR signaling mechanisms Jean-Pierre Vilardaga
October 3, 2013 Seeing is Believing – Imaging the Processes of Life Session 6 Correlative Imaging Jeff Lichtman
September 8, 2013 14th International Conference on Alzheimer's Drug Discovery Characterizing the Mitophenotypes of Alzheimer’s Disease: Peripheral Cell Biomarkers for Patient Selection and Measurement of Drug Response Marcie Glicksman
July 21, 2013 54th Annual Short Course on Medical and Experimental Mammalian Genetics C hromosome Struc ture and Function Jeanne Lawrence
Saturday, July 27 Pecking at the Origin of Natural Variation: Insights from Darwin’s Finches and Other Birds Arkhat Abzhanov
Friday, August 2 Reawakening Fetal Hemogl o bin for Therapy: An Old Problem with New Prospects Stuart Orkin
June 3, 2013 Asia Biotech Invest 2013 Investment Panel: What’s hot in life sciences? Investment themes for 2013-2015 Jonathan Wang
Panel: Investing in China biotech Jonathan Wang
May 31, 2013 ASCO Annual Meeting 2013 Optimizing the Role of Advanced Practice Professionals in Oncology Practice Lawrence N. Shulman
Hot Pathways for Targeted Therapy of B-Cell Malignancies James E. Bradner
Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer Ian E. Krop
Clinical Management, Molecular Alterations, and Future Perspectives in Urothelial Cancer David Kwiatkowski
Cancer Stem Cells: A New and Better Target in Pediatric Oncology? Scott A. Armstrong, George Daley
Reaping the Rewards of the Cancer Genome Atlas Project Levi A Garraway
Improving Cancer Care through Health Information Technology: Ethics and Practicality Lawrence N. Shulman
Education Sessions Robert G Maki, Stephen T Sonis
Education Sessions Deborah Schrag
Education Sessions Tracy T Batchelor
Education Sessions Michael B. Atkins, Jennifer A. Ligibel
Educations Sessions Monica M. Bertagnolli
Education Sessions Bruce E. Johnson, Elizabeth R. Gerstner
May 8, 2013 Chromatin and epigenetics Kevin Struhl, Harvard Medical School, USA Kevin Struhl
Robert Kingston, Massachusetts General Hospital, USA Robert Kingston
Craig Peterson, University of Massachusetts Medical School, USA Craig L Peterson
May 1, 2013 New Model Systems for Linking Evolution and Ecology Session 4 - Emerging models - animals Chair: Bettina Harr, MPI for Evolutionary Biology, Germany Arkhat Abzhanov
May 1, 2013 SymposiumonAdvancedWoundCareSpringandWoundHealingSociety GENERAL SESSION: OPENING KEYNOTE ADDRESS Gary W. Gibbons
May 1, 2013 EMBO | EMBL Symposium: New Model Systems for Linking Evolution and Ecology Developmental mechanisms for morphological evolution: Insights from birds and lizards Arkhat Abzhanov
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Anjana Rao, James E. Bradner
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Stuart H. Orkin
Blood-Based Molecular Analysis of Cancer Daniel A Haber
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Joan S Brugge
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Leonard I. Zon
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Claude Lechene
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Timothy J Mitchison
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Karen Cichowski
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Stephen J Elledge
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Anthony G. Letai
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Kornelia Polyak
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Jeannie T. Lee
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Frank McKeon
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Matthew Smith
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, William C Hahn
Avatar: Individualized Human Cancer Models in Mice Kwok-Kin Wong
Next-Generation Therapeutic Modeling in Mice Pier Paolo
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Levi A Garraway
Clinical Trials Based on Mutations versus Histology William R Sellers, Lewis C Cantley
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Peter M Howley
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Kwok-Kin Wong
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony G. Letai
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Scott A. Armstrong
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA James E. Bradner
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Xandra O Breakefield
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
Cancer Omics Beyond the Genome Sunney Xie
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Kornelia Polyak
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Tan Ince
WICR Career Mentoring Session Joan S Brugge
February 19, 2013 Nutrition, Epigenetics and Human Disease (B5) Epigenomic Analysis of Adipose Biology Evan Rosen
Genome Editing to Generate Human Cellular Models of Metabolic Disease Chad A. Cowan
February 10, 2013 7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs Drug Discovery Services for Preclinical Drug Discovery: Centers & CROs Marcie Glicksman
Session Overview Marcie Glicksman
February 3, 2013 Neurogenesis (J7) Welcome and Keynote Address Li Huei Tsai
Model Systems Christopher Walsh
Stem Cell Niches in the Developing and Adult Brain Christopher Walsh
iPSC Modeling of Developmental and Degenerative Neurological Diseases (Joint) Li Huei Tsai
January 31, 2013 5th Immunotherapeutics & Immunomonitoring KEYNOTE PRESENTATION Jeffrey J. Popma
January 20, 2013 Tumor Invasion and Metastasis GEM models in translational research Lynda Chin
Regulation of metastasis via tumor-stromal interactions Randolph S Watnick
Session 8: Treatment of Metastatic Cancer Bruce R. Zetter
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Regenerative Medicine David T Scadden
Career-Development Lunch Sessions D. Gary Gilliland, Daniel J. DeAngelo, David Avigan, Ellis J. Neufeld
December 4, 2012 CTRC-AACR San Antonio Breast Cancer Symposium Mini-Symposium 1 - The mTOR pathway: Role in Metabolism and as a Therapeutic Target - Exhibit Hall D Lewis Cantley
April 1, 2012 Regenerative Tissue Engineering and Transplantation (Z3) Cells and Biological Mechanisms I Kevin Eggan
New Vistas in Tissue Regeneration and Engineering (Joint) Kenneth R Chien
March 25, 2012 ISA 2012 - XVI International Symposium on Atherosclerosis Healthy Drinking an Important Component of Healthy Eating Frank B. Hu
March 4, 2012 Protein-RNA Interactions in Biology and Disease (C1) Genetic Diseases Caused by Alterations of RBP or RNA Sequence: Part 1 Thomas Maniatis
January 8, 2012 Noncoding RNAs and Cancer X-inactivation, RNA, stem cells, and cancer Jeannie T. Lee
Mechanism of RNAi-mediated heterochromatin assembly Danesh Moazed
Session 2 | Chromatin Modifications Danesh Moazed
Session 1 | Long Noncoding RNAs Jeannie T. Lee
Functional genomics, small RNAs, and cancer William C Hahn
Session 7 | RNA in Cancer and Disease William C Hahn
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Welcome and Opening Remarks Judy Garber
Epigenetics of hormone dependence Myles Brown
December 9, 2011 2nd Oxford Symposium on Epigenetic Mechanisms in Health and Disease Session 1 | An epigenetic switch linking inflammation to cancer Kevin Struhl
October 20, 2011 Nature Chemical Biology Symposium 2011: Cancer Chemical Biology Relating genetic features of human cancers to smallmolecule drug efficacies Stuart Schreiber
Welcome and Opening Remarks Gregory L Verdine
Bromodomain inhibition in cancer James E. Bradner
Introduction Ralph Mazitschek
Introduction Andrew Kung
Targeting metabolic enzymes for cancer therapy Lewis Cantley
Closing Remarks Gregory L Verdine
October 13, 2011 EMBO|EMBL Symposia:Structure and Dynamics of Protein Networks Keynote Session | Dynamics of endocytosis T. Kirchhausen
August 20, 2011 20th Annual Short Course on Experimental Models of Human Cancer Tumor Angiogenesis And Microenvironment Rakesh K Jain
Modeling the Ras Pathway in Cancer Karen Cichowski
Zebrafish Models to Dissect Human Cancer Pathways Thomas A. Look
EGFR Pathways and Cancer Pasi A Janne
Personalized medicine Raju Kucherlapati
June 20, 2011 Changing Landscape of the Cancer Genome (F3) Somatic Genome Alterations in Human Lung Cancer Matthew Meyerson
GBM Lynda Chin
Characterizing the Prostate Cancer Genome Levi A Garraway
Talk Title to be Determined Richard Wilson
Protein Interactome Marc Vidal
June 20, 2011 Cancer Proteomics 2011 - Systems Biology, Developmental Models and Data Integration Interactome networks & human disease Marc Vidal
May 26, 2011 Idibell Cancer Conference on Metastasis and Angiogenesis Tumor microenvironment controls the rate of metastasis Raghu Kalluri
May 18, 2011 SBI 10th Postgraduate Course Challenging Cases MRI (Audience Response System) Sughra Raza
Gerald Dodd Lecture | Biology Of Breast Cancer Stuart J Schnitt
May 15, 2011 Lipid Biology and Lipotoxicity (E2) Lipid Droplet Proteins in the Control of Peripheral Insulin Sensitivity Michael P. Czech
May 10, 2011 The Molecular and Cellular Mechanisms, Regulating Skeletal Muscle, Development and Regeneration Regulation of higher order chromatin structure and gene positioning during myogenesis Tony Imbalzano
New Insights into the Molecular Mechanisms of Muscle Atrophy Alfred L. Goldberg
May 8, 2011 Omics Meets Cell Biology (E1) Large-Scale Analyses of Signaling Networks Norbert Perrimon
May 2, 2011 LIPID MAPS Annual Meeting 2011: Lipidomics Impact on Cell Biology, Cancer, and Metabolic Diseases Mechanisms and targets of Leukotriene E4 in pulmonary inflammation Joshua A. Boyce
PI 3-Kinase, metabolism and disease Lewis C Cantley
February 27, 2011 Evolutionary Developmental Biology (C1) Adaptive Evolution of Beach Mice Hopi E. Hoekstra
Short Talk: Evolution and Development of Beak Diversity in Darwin's Finches and their Relatives Ricardo Mallarino
Genetic Architecture of Trait Evolution Hopi E. Hoekstra
February 26, 2011 Immunity in the Respiratory Tract: Challenges of the Lung Environment (X6) Mucosal Biology (X5) | Protein Domains, Signaling Networks, and Immunity Ramnik J. Xavier
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) Innovative Approaches in Modern Medicine and Vaccine Development | Protein Domains, Signaling Networks, and Immunity Ramnik J. Xavier
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Primary Central Nervous System Lymphoma Tracy T Batchelor
Management of Autoimmune Issues in Chronic Lymphocytic Leukemia Jennifer R. Brown
Comment Jennifer R. Brown
CDK Inhibitors Noopur Raje
PI3K | Akt Pathway Inhibitors Jennifer R. Brown
BCR | Downstream Therapeutic Targets Jennifer R. Brown
Aggressive Lymphoid Malignancies (Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia, Burkitt Lymphoma) Daniel J. DeAngelo
Outlook for Management of Bone Disease in Multiple Myeloma Noopur Raje
Multiple Myeloma Noopur Raje
Acute Myeloid Leukemia | Myelodysplastic Syndromes Daniel J. DeAngelo
February 13, 2011 Inositide Signaling in Pharmacology and Disease (X1) Keynote Session (Joint) | The Role of Phosphoinositides in Human Disease Lewis C Cantley
PI 3-Kinases (X2) | PI3K Pathway in Tumor Cell Metabolism and Matrix Control Joan S Brugge
PI 3-Kinases (X2) | mTOR Controls Cellular Metabolism Downstream of PI3K Brendan Manning
PI 3-Kinases (X2) | Optimizing PI3K Targeting in Cancer, Mechanistic Insights Jeffrey Adam Engelman
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Adaptive Immunity against Cancer? | Mechanisms of Protective Tumor Immunity Glenn Dranoff
February 6, 2011 5th Drug Discovery for Neurodegeneration: An Intensive Course for Translating Research into Drugs Academic Models of Drug Discovery Services & Utilizing CROs Marcie Glicksman
February 6, 2011 Salivary Glands & Exocrine Biology Neural regulation of lacrimal gland signaling and secretion Darlene A Dartt
Inflammation and Autoimmunity Darlene A Dartt
January 12, 2011 "Nano in Cancer": Linking Chemistry, Biology, and Clinical Applications In Vivo Session 3: Biomarkers and Diagnostics Ralph J Weissleder
Cancer cell profiling with DMR Ralph J Weissleder
January 12, 2011 Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction (J1) Genetic and Pharmacological Interventions to Treat Age-related Diseases | Columbine Ballroom David A Sinclair
Systems Analysis of Mitochondrial Function | Columbine Ballroom Vamsi K Mootha
Transcriptional Regulation of Adipogenesis and Energy Homeostasis | Columbine Ballroom Bruce Spiegelman
Insulin Resistance, Mitochondrial Dysfunction and Lipotoxicity in Humans | New and Novel Aspects of Insulin Signaling and Insulin Resistance C. Ronald Kahn
Panel: Mechanisms of Insulin Resistance: Recent Advances and Current Controversies (Joint) | Columbine Ballroom Barbara Kahn
January 12, 2011 Obesity (J2) Genetic and Pharmacological Interventions to Treat Age-related Diseases | Columbine Ballroom David A Sinclair
Systems Analysis of Mitochondrial Function | Columbine Ballroom Vamsi K Mootha
Transcriptional Regulation of Adipogenesis and Energy Homeostasis | Columbine Ballroom Bruce Spiegelman
Diabetes (J1) | New and Novel Aspects of Insulin Signaling and Insulin Resistance C. Ronald Kahn
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium DNA Repair | Ballroom C-3 Daniel P. Silver
DNA repair and breast cancer: Therapeutic opportunities and challenges Daniel P. Silver
Measuring and modeling cell death pathways in tumor cells Peter K. Sorger
Panel Discussion Judy E Garber
Clinical Science Forum - Controversies in Screening for Breast Cancer | Ballroom A Eric P. Winer
The role of providers in breast cancer disparities Nancy L. Keating
November 13, 2010 From Functional Genomics to Systems Biology Session II: Gene expression Job Dekker
November 3, 2010 Eighth Annual RNAi for Functional Screens Forcing Glioblastoma Tumor Initiating Cells to Differentiate: An High Throughput, High Content Imaging Screen to Target Transcription Factors and GTPases Milan G Chheda,
October 27, 2010 Colorectal Cancer: Biology to Therapy Molecular imaging approaches to colorectal cancer Umar Mahmood
September 27, 2010 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers Opening Remarks Rakesh K Jain
Tumor Microenvironment I: Angiogenesis and Vascular Transport Rakesh K Jain
Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapy: from Bench to Bedside to Biomarkers Rakesh K Jain
Tumor Microenvironment II: Interstitial and Lymphatic Transport Rakesh K Jain
Tumor Stroma Generation: Role of VPF/VEGF Harold F. Dvorak
Mining the Human Proteome: Biomarker Discovery for Human Cancer and Its Metastases Marsha Moses
Genetics in Cancer Therapy Raju Kucherlapati
Imaging Angiogenesis and Vascular Function in Cancer Patients A. Gregory Sorensen
September 22, 2010 Chemical Biology 2010 Lecture by Gavin MacBeath Gavin MacBeath
September 5, 2010 EMBO|EMBL Symposium: Structure and Function of Neural Circuits Keynote Lecture Jeff Lichtman
Neurobiology of Motivation and Emotion | By Catherine Dulac Catherine Dulac
Cerebellum and Motor Systems | By Florian Engert Florian Engert
Information Processing in Sensory Systems | By Mark Daly Mark Daly
Information Processing in Sensory Systems | By Rachel Wilson Rachel Wilson
Information Processing in Sensory Systems | By Markus Meister Markus Meister
July 15, 2010 Osteoporosis 2010: New Insights in Research, Diagnosis, and Clinical Care Beyond BMD: Bone Quality and Bone Strength Mary L. Bouxsein
Special Topics in Osteoporosis Mary L. Bouxsein
July 11, 2010 3rd International Congress On Stem Cells And Tissue Formation Biomaterials for Cell Transplantation and Drug Delivery | Amy Brock Amy Brock
Programming Cells In Vivo Using Polymers David J. Mooney
June 17, 2010 Institute of Structural and Molecular Biology 4th Symposium Drugging Oncogenic Transcription Factors Gregory Verdine
June 12, 2010 Genetics 2010: Model Organisms to Human Biology Session 1: Personal Genomics David Altshuler
Keynote Address: Gary Ruvkun
Workshops: High-Throughput RNAi Screening in Model Systems used to Study Human Biology at Genome Scale Workshop Liz Perkins, Stephanie Mohr
Session 7: Stem cell: the genetics of commitment Anjana Rao, George Daley
Session 6: Modern approaches to pathogenesis and infectious disease John Mekalanos
Session 5: Neurogenetics: from synapses to senescence Li Huei Tsai, P Sklar
Session 8: Organismal architecture and developmental disabilities Matt Warman
May 19, 2010 Towards Personalized Cancer Medicine New Cancer Targets Emerging From Studies of the von Hippel-Lindau Tumor Suppressor Protein William G Kaelin
Functionalizing the Cancer Genome Lynda Chin
SESSION III: Oncogenomics and Tumor Profiling Lynda Chin
Target and Drug Discovery in Oncology: The Right Drug for the Right Patient D. Gary Gilliland
PANEL DISCUSSION Lynda Chin
May 3, 2010 LIPID MAPS Annual Meeting 2010: Lipidomics Impact on Cell Biology, Atherosclerosis and Inflammatory Disease Foam cells and immunology of obesity Steven Shoelson
April 30, 2010 UCSF Radiation Oncology Update: Management of Recurrent Disease Buschke Lecture: The Relationship Between Local Recurrence and Survival in Breast Cancer Jay R Harris, MD
Approaches for Endometrial Recurrence Phillip M. Devlin
April 11, 2010 Molecular Targets for Control of Vector-Borne Diseases: Bridging Lab and Field Research (F2) * Multigene Families: Role in Immunity and Pathology | Big Horn B Peter R. Preiser
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit China's Healthcare Reform: Implications for the Industrial Sectors Yuan-Li Liu
January 20, 2010 12th International Conference on Dialysis Gelsolin: biology and clinical correlates Ravi Thadhani
November 2, 2009 Track 2: Third Annual HDAC Inhibitors Chemical Phylogenetics of Human Histone Deacetylases James E. Bradner
November 2, 2009 Track 1: Seventh Annual RNAi for Screening Cellular Pathways and Targets Title to be Announced Stephen J Elledge
Efficient Vectors for in vivo RNAi and Construction of a Drosophila Genome-wide Transgenic RNAi Collection Norbert Perrimon
Chairperson’s Opening Remarks Norbert Perrimon
September 21, 2009 Third Annual Exploring Next Generation Sequencing Targeted Sequencing of Human Genomes, Transcriptomes and Methylomes Jin Billy Li
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery The chemical biology of behavior and psychiatric disease Randall Peterson
Drugging the "undruggable" Gregory Verdine
August 5, 2009 New Frontiers in Cancer Drug Development A New Paradigm for Translational Cancer Research: Targeting Endocrine Factors and Real Human Tumors Sandra S. McAllister
Turning Cancer Sequencing Data into Therapeutic Targets Heidi Greulich
Combinations of Novel and Conventional Cancer Agents: Challenges and Opportunities Kenneth C Anderson
The Use of Genetically Engineered Mouse Lung Cancer Models to Assess Effectiveness of Targeted Therapeutic Combinations Kwok-Kin Wong
The Evolving Treatment Paradigm in Multiple Myeloma Kenneth C Anderson
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Michael Foley, Ph.D. Build-Couple-Pair Strategy for Diversity-Oriented Synthesis Yields a Unique Compound Collection for Probe Development and Drug Discovery Michael Foley
In Vivo Chemical Screening in Zebrafish Joanna Yeh
June 22, 2009 Symposium: Light Microscopy meets Structural Biology Combining structural and FRET studies to investigate the activational switch of Focal Adhesion Kinase Daniel Lietha
April 22, 2009 Complex Lipids in Biology: Signaling, Compartmentalization and Disease (Z4) Phosphoinositides and Signaling (Joint) Lewis C Cantley
February 28, 2009 Biophysical Society 53rd Annual Meeting Symposium 4: Systems Biology Pamela Silver
Symposium 6: Store-operated Calcium Channels in the Molecular Age Stefan Feske
Symposium 8: Monitoring RNAs: From Single Molecules to the Cell Xiaowei Zhuang
Symposium 12: Regulated Intramembrane Proteolysis (RIP) Michael S. Wolfe
Symposium 16: Channels, Transporters, and Pores: Ways to Cross the Membrane Thomas Walz
January 26, 2009 7th Annual Partnering with Central Labs Track A : Central Lab Cost Drivers and Logistics Discussion Forum David Mooney
December 7, 2008 AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting SIG 1: Syndecan1 Shedding: An Innate Immune Response to Infection Pyong Woo Park
December 7, 2008 Antibody Engineering Adapting Antibodies According to Target Diversity in Viral Diseases and Cancer Wayne A Marasco
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) TBD Yu-Li Wang
Co-Chair :Track 2-8 Zhen Y. Jiang
Analyzing Insulin Signaling Networks and Metabolic Functions Using Quantitative Proteomics Approach :Track 2-8 Zhen Y. Jiang
Oral Delivery of Glucan Encapsulated siRNA to Macrophages Targeting Map4K4 Attenuates Systemic Inflammation :Track 2-8 Myriam Aouadi
Developmental Origin of Adipose Tissue: Novel Role of Bone Morphogenetic Proteins in Adipogenesis and Energy Metabolism :Track 2-8 Yu-Hua Tseng
Title: TBD : Track 4-4 Jing X. Kang
November 20, 2008 The 13th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology Introduction and Overview Patrick Y. Wen
Resistance to Cytotoxic Therapies Arnab Chakravarti
Inducing Apoptosis and Inhibiting Autophagy Andrew Kung
Biology of RNAi William C Hahn
Delivery of RNAi to brain tumors Khalid Shah
October 22, 2008 Targeting Diabetes With Novel Therapeutics Chemical Screening for Modulators of Beta Cell Differentiation and Proliferation Julia Lamenzo
A Systems Biology Approach to Dissecting the Topology of the Insulin Signaling Network Norbert Perrimon
October 21, 2008 RNAi for Screening Cancer Proliferation Gene Discovery Through Functional Genomics Stephen J Elledge
A Systems Biology Approach to Dissecting the Topology of the Insulin Signaling Network Norbert Perrimon
August 18, 2008 Systems Integration in Biodefense Leveraging Cell Phone Technology to Make Point-of-Care Diagnostics Accessible in the Developing World Boris Nikolic
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Morning Symposia 2: Proteomics [sponsored by Merck Research Laboratories] Claude Lechene
Concurrent Morning Symposia 12: Systems Biology Josh LaBaer
June 11, 2008 6th ISSCR Annual Meeting Plenary I: Presidential Symposium on Developmental Biology George Daley
DIRECT REPROGRAMMING TO MAKE PANCREATIC β CELLS Douglas Melton
Standards and Methodology of iPS Cells Panel Discussion George Daley
GENOMEWIDE STUDIES OF THE PLURIPOTENT CHROMATIN STATE Brad Bernstein
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer genetics-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer prevention/epidemiology-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
clinical trials-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
ethics-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
gastrointestinal (noncolorectal) cancer-- Gastrointestinal Stromal Tumor (GIST) Comes of Age: Current Management Using Molecular Pathology, Surgery, and Targeted Therapy George Daniel Demetri
geriatric oncology--Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
lung cancer-- Targeted and Novel Agents in Small Cell Lung Cancer Bruce E. Johnson
melanoma/skin cancers-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
patient and survivor care-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
patient and survivor care-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
pediatric cancer-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
pediatric cancer-- Challenges and Optimizing Outcomes in Adolescents and Young Adults with Cancer Karen H. Albritton
pediatric cancer-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
pediatric cancer-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
sarcoma/bone and soft tissue cancers-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
sarcoma/bone and soft tissue cancers-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
tumor biology-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
meet the professor sessions-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
May 18, 2008 COMPUTATIONAL ASPECTS - BIOMOLECULAR NMR Metabolic Changes Due to Expression of Oncogenes Gerhard Wagner
April 30, 2008 RNAi World Congress Dual Role for Argonaute Proteins in microRNA Processing and Post-Transcriptional Regulation of microRNA Expression Sven Diederichs
RNAi: From Mechanism to Medicine Craig Mello
March 30, 2008 Nuclear Receptors: Steroid Sisters Steroid Receptors and Chromatin Myles Brown
Analyses of Nuclear Receptor-Dependent Transcription (Joint) Myles Brown
Workshop 3 - Hot Topics: Chromatin/Transcription Mathieu Lupien
Steroid Receptor Biology Inna I. Astapova
Mechanisms of Receptor Action Pere Puigserver
Nuclear Receptor Biology (Joint) Bruce Spiegelman
March 30, 2008 Nuclear Receptors: Orphan Brothers Steroid Receptors and Chromatin Myles Brown
Analyses of Nuclear Receptor-Dependent Transcription (Joint) Myles Brown
Workshop 3 - Hot Topics: Chromatin/Transcription Mathieu Lupien
Mechanisms of Receptor Action Pere Puigserver
Steroid Receptor Biology Inna I. Astapova
Nuclear Receptor Biology (Joint) Bruce Spiegelman
March 25, 2008 PATHWAY ANALYSIS Chairperson’s Remarks Tara M Love
Not miR-ly Small RNAs: Genetic Approach to Defining microRNA Pathways Tara M Love
March 25, 2008 RNAi, MicroRNA, and Non-Coding RNA Keynote Session Craig Mello
RNA Interference: Regulation of Transcription Danesh Moazed
Workshop 1: New Approaches to shRNA-Based Screening and Therapy Edward Harlow
RNAi-Based Screening Gary Ruvkun
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic Title to be announced William G Kaelin
Clinical Targeting and Inhibition of Tyrosine Kinases in GIST and Sarcomas: Lessons for Cancer Therapy and Future Directions George Daniel Demetri
RNAi, NON-CODING RNA, AND microRNA William C Hahn
Functional Genomics, Experimental Models, and Cancer William C Hahn
March 9, 2008 Biology OF Acute Respiratory Infection Population dynamics Marc Lipsitch
BACTERIAL ACUTE RESPIRATORY INFECTIONS Marc Lipsitch
Scavenger receptors and innate immunity Lester Kobzik
ANTIMICROBIAL IMMUNE EFFECTOR MECHANISMS Lester Kobzik
February 17, 2008 GRC - Glycolipid & Sphingolipid Biology Arrival and Check-in (Office Closed 6:00 pm - 7:45 pm) Test User
Cell non-autonomous function of ceramidase in photoreceptor homeostasis Usha Acharya
January 6, 2008 Structural Genomics and its Applications to Chemistry, Biology and Medicine Following Session is for Structural Biology (J1) Macromolecular Dynamics: Experiment and Theory Gerhard Wagner
Following Session is for Structural Biology (J1) Membrane Protein Structure James Jeiwen Chou
Pushing the Limits of Structural Biology II: Advances in Methodologies for Structure Determination (Joint) Gerhard Wagner
Proteomics and Protein Assemblies/Networks Alexander B. Sigalov
January 6, 2008 Frontiers of Structural Biology Macromolecular Dynamics: Experiment and Theory Gerhard Wagner
Membrane Protein Structure James Jeiwen Chou
Pushing the Limits of Structural Biology II: Advances in Methodologies for Structure Determination (Joint) Gerhard Wagner
December 1, 2007 47TH American Socieity of Cell Biology Design Principles for Connecting the Genome to the World I Philips, C. Ajo-Franklin
Minisymposium 1A:Cell Biology Working Group: Challenges in Cell Biology—The Nature of Cytoplasm Timothy J Mitchison
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells. C. Zhang
*Single-Molecule Analysis Reveals the Distribution of Potential vs. Active DNA Replication Origins in Human Cells R. Lebofsky
Cell Matrix Interactions (Room 140A) Yu-Li Wang
Advances in Bone Cell Molecular Biology: Epigenetic Control Jane Lian, Gary S Stein
CLASPs Clutching Microtubule Networks (Room 209 B/C) David Van Vactor
At the Limits: Optical Methods for Single Molecules, Cells, and Organisms Jennifer Waters, Samara Rech-Peterson
High Performance Image Analysis and Photomanipulative Techniques for Jeffrey Nickerson
Building the Cell (Room 140B) L Mahadevan
Systems Biology of Receptor Tyrosine Kinase Networks (Room 206) Peter K. Sorger
Public Service Award Presentation Matthew Michael
Primary Role for Centrosome Proteins in Cilia Formation and Cilia-associated Disorders B Delaval, L Covassin Barberis, N Lawson, Stephen J Doxsey
Cell-Type Variation in Responses to Anti-mitotic Drugs. C Loy, J Orth, C Shamu, M Tsui, V Yanamadala, Timothy J Mitchison
Fluorescence Correlation Spectroscopy Workshop Daniel Needham
Actin Disassembly by Whole-Filament Destabilization.v H Kueh, W M Brieher, Timothy J Mitchison
How Does Thrombospondin Induce CNS Synaptogenesis? J. T. Lawler
Identifying Matrix- and Growth Factor-induced Transcriptional Dichotomies by Stochastic Sampling. K A Janes, Joan Brugge
High-Tech Cell Biology Kendall Knight
DNA Damage Signaling Events Revealed by 4Pi Microscopy. Kendall Knight, Brian T Bennett
Novel Microscopy Methodology to Examine DNA Damage Signaling and Repair. Brian T Bennett
Heterochromatin Formation in Fission Yeast. M Huarte, Yang Shi
Anti-fi brotic Property of CTGF siRNA in the Liver via Targeted Delivery to Hepatic Stellate Cells. David Roger Brigstock, C Lawrencia
Mallory Body Formation in the Livers of Drug-primed Mice Is Regulated by an Epigenetic Mechanism Jian Li
Myosin-activated Random Stress Fluctuations in the Actin Cytoskeleton David Weitz
Cytoplasmic Dynein Is a Better Navigator than Kinesin on Tau-decorated Microtubules. J. L. Ross
Determining the Molecular Architectures of Cellular Machines by Satisfaction of Spatial Restraints: The Nuclear Pore Complex. Adrian Salic
Posters Displayed:Monday Joan Brugge
Amaxa GmbH: Alan D Andrea
Post-Cytokinetic DNA Segregation by ATPases That Form DNA-Conducting Channels Tom A Rapoport, N L Sullivan, K Marquis
Maintenance of Polarity and Cell Shape in Vibrio cholerae Matthew K Waldor
Biochemical Characterization of Type III-secreted Bacterial Acetyltransferases J Orth
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Irene Bosch
Session 11: Identification of Novel and Effective Antiviral Treatment and zstablishment of Disease Pathogenesis: A journey of Global Gene Expression of dengue virus infection (11:20-11:40) Irene Bosch
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) RNAi as a Predictive Tool (14:20-15:25) Yaakov Benenson
RNAi as a Predictive Tool: RNAi-Based Molecular Logic Circuits (14:55-15:25) Yaakov Benenson
RNAi FOR IN VIVO TARGET VALIDATION (16:30-19:30) Anna Moore
RNAi FOR IN VIVO TARGET VALIDATION: In Vivo Imaging of siRNA Delivery and Silencing in Tumors (17:00-17:30) Anna Moore
September 7, 2007 The 2007 Breast Symposium The Impact of Local Treatment on Long-Term Survival: Local Control Matters Jay R Harris, MD
Premalignant Lesions: Ductal Carcinoma in Situ, Lobular Carcinoma in Situ, and Other Lesions that Increase the Risk of Invasive Breast Cancer Laura C. Collins
Is Axillary Dissection Needed in Node (+) Breast Cancer? Mehra Golshan
Is There an Optimal Way of Integrating Postmastectomy Radiation Therapy and Reconstruction? Abram Recht
August 4, 2007 Glucose Transporter Biology Nutrient and Energy Sensing: Transcriptional Acetylation Enzymes Connected to Metabolic Cellular Responses Pere Puigserver
Inflammation and insulin resistance Steve Shoelson
The WD40 and FYVE domain containing protein-2 (WDFY2) links Akt function and Rab activation Silvia Corvera
Regulation of glucose transport, Physiology Shaohui Huang
Molecular Mechanisms of GLUT4 Recycling Tony Imbalzano
June 16, 2007 Biology and Chemistry of Vision Functional Studies of Usher Proteins in Murine Tiansen Li
June 16, 2007 Thrombospondins and other Matricellular Proteins In Tissue Organization and Homeostasis Receptors and Cellular Networks Jack Lawler
Thrombospondin-1 affects the organization and function of endothelial cell membrane proteins Jack Lawler
Mechanisms of thrombospondin-1-mediated apoptosis Roya Khosravi Far
Regional endogenous anti-angiogenesis Judah Folkman
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.